Sections
Shortcuts
Business

BG Medicine stock surges after net loss narrows, revenue rises

BG Medicine focuses on developing diagnostics to help manage heart failure and related disorders.
BG Medicine focuses on developing diagnostics to help manage heart failure and related disorders.

This is a summary. To read the whole story subscribe to BostonGlobe.com

BG Medicine Inc., a Waltham life-sciences company, said its quarterly revenue rose 7 percent to $1.15 million, compared with the year-earlier period. The net loss for the quarter came in at 6 cents per share, below the loss of 14 cents a year before. Revenue for the full year 2013 was $4.1 million, a 45 percent increase. Net loss for 2013 was $15.8 million, a 33 percent improvement.The company also said it has been issued a US patent on methods of predicting responsiveness to cardiac resynchronization therapy by the measurement of the concentration of the protein galectin-3 in blood.

Full story for BostonGlobe.com subscribers.

Get the full story with unlimited access to BostonGlobe.com.

Just 99 cents for four weeks.

Sections
Shortcuts

Share